Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial

Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial

(2010) Benjamin M. Scirica et al.   EUROPEAN HEART JOURNAL

Prospective Evaluation of the Prognostic Implications of Improved Assay Performance With a Sensitive Assay for Cardiac Troponin I

(2010) Marc Bonaca et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Criteria for Evaluation of Novel Markers of Cardiovascular Risk

(2009) Mark A. Hlatky et al.   CIRCULATION

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prognostic Value of Biomarkers During and After Non–ST-Segment Elevation Acute Coronary Syndrome

(2009) Kai M. Eggers et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Assessing New Biomarkers and Predictive Models for Use in Clinical Practice

(2008) Kevin McGeechan et al.   ARCHIVES OF INTERNAL MEDICINE

Effect of Collection Tube Type and Preanalytical Handling on Myeloperoxidase Concentrations

(2008) J. Shih et al.   CLINICAL CHEMISTRY

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18

(2008) David A. Morrow et al.   EUROPEAN HEART JOURNAL